CN1056876C - 制备口服用活伤寒疫苗的培养方法 - Google Patents

制备口服用活伤寒疫苗的培养方法 Download PDF

Info

Publication number
CN1056876C
CN1056876C CN91108798A CN91108798A CN1056876C CN 1056876 C CN1056876 C CN 1056876C CN 91108798 A CN91108798 A CN 91108798A CN 91108798 A CN91108798 A CN 91108798A CN 1056876 C CN1056876 C CN 1056876C
Authority
CN
China
Prior art keywords
bacterium
hours
bacteria
medium
frost drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN91108798A
Other languages
English (en)
Chinese (zh)
Other versions
CN1060110A (zh
Inventor
朴凤和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BORYUNG BIOPHARMA CO LTD
Original Assignee
BORYUNG BIOPHARMA CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BORYUNG BIOPHARMA CO LTD filed Critical BORYUNG BIOPHARMA CO LTD
Publication of CN1060110A publication Critical patent/CN1060110A/zh
Application granted granted Critical
Publication of CN1056876C publication Critical patent/CN1056876C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CN91108798A 1990-09-05 1991-09-05 制备口服用活伤寒疫苗的培养方法 Expired - Lifetime CN1056876C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019900014019A KR930001382B1 (ko) 1990-09-05 1990-09-05 경구용 장티프스 생균백신 및 그의 제조방법
KR14019/1990 1990-09-05
KR14019/90 1990-09-05

Publications (2)

Publication Number Publication Date
CN1060110A CN1060110A (zh) 1992-04-08
CN1056876C true CN1056876C (zh) 2000-09-27

Family

ID=19303271

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91108798A Expired - Lifetime CN1056876C (zh) 1990-09-05 1991-09-05 制备口服用活伤寒疫苗的培养方法

Country Status (8)

Country Link
JP (1) JPH0771471B2 (fr)
KR (1) KR930001382B1 (fr)
CN (1) CN1056876C (fr)
CH (1) CH683187A5 (fr)
ES (1) ES2037599B1 (fr)
GB (1) GB2248241B (fr)
IL (1) IL99138A (fr)
TW (1) TW209244B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727128B1 (fr) * 1994-11-17 1997-01-17 Fdm Pharma Moyens pour le traitement de prelevements susceptibles de renfermer des microorganismes pathogenes
GB0900350D0 (en) * 2009-01-09 2009-02-11 Cambridge Entpr Ltd Formulations of viable bacteria for oral delivery
RU2631924C2 (ru) * 2011-12-22 2017-09-28 Ваксимм Аг Высокопродуктивный способ получения ослабленных штаммов salmonella
SG11201500054QA (en) 2012-07-05 2015-03-30 Vaximm Ag Dna vaccine for use in pancreatic cancer patients
GB2564481B (en) * 2017-07-14 2019-10-23 4D Pharma Leon S L U Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856935A (en) * 1971-04-29 1974-12-24 Schweiz Serum & Impfinst Oral typhoid vaccine and method of preparing the same
JPS5522448A (en) * 1978-08-03 1980-02-18 Shin Meiwa Ind Co Ltd Rotary working table
US4632830A (en) * 1981-07-31 1986-12-30 The United States Of America As Represented By The Secretary Of The Army Oral vaccine for immunization against enteric disease
US4879239A (en) * 1983-11-03 1989-11-07 American Type Culture Collection Method of culturing freeze-dried microorganisms and resultant preparation

Also Published As

Publication number Publication date
TW209244B (fr) 1993-07-11
IL99138A0 (en) 1992-07-15
GB2248241B (en) 1995-01-04
ES2037599B1 (es) 1994-02-01
CH683187A5 (fr) 1994-01-31
IL99138A (en) 1995-10-31
KR930001382B1 (ko) 1993-02-27
CN1060110A (zh) 1992-04-08
JPH05336950A (ja) 1993-12-21
GB2248241A (en) 1992-04-01
GB9117918D0 (en) 1991-10-09
JPH0771471B2 (ja) 1995-08-02
KR920006496A (ko) 1992-04-27
ES2037599A1 (es) 1993-06-16

Similar Documents

Publication Publication Date Title
Jawetz A pneumotropic Pasteurella of laboratory animals. I. Bacteriological and serological characteristics of the organism
MacLeod et al. Stepwise intratype transformation of pneumococcus from R to S by way of a variant intermediate in capsular polysaccharide production
Pierce-Chase et al. Corynebacterial pseudotuberculosis in mice: I. Comparative susceptibility of mouse strains to experimental infection with Corynebacterium kutscheri
CN1056876C (zh) 制备口服用活伤寒疫苗的培养方法
Abrahamsson et al. The effect of temperature on toxin formation and toxin stability of Clostridium botulinum type E in different environments
CN1224695C (zh) 用昆虫培育冬虫夏草的新技术
Snieszko et al. A new bacterium (Hemophilus piscium n. sp.) from ulcer disease of trout
US3401219A (en) Moraxella bovis infectious bovine keratoconjunctivitis steam-killed bacterin
Schmitt-Slomska et al. Group A Streptococcal L Forms I. Persistence Among Inoculated Mice
US3548055A (en) Infectious bursal disease vaccine
US5225194A (en) Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases
Colling et al. TOXINS OF PSEUDOMONAS PSEUDOMALLEI: I. Production in vitro
CN85101971A (zh) 中国冬虫夏草真菌及其人工培养方法
Duval The cultivation of the leprosy bacillus and the experimental production of leprosy in the Japanese dancing mouse
Cooper et al. In vitro kinetics of phagocytosis and intracellular killing of gonococci by peritoneal macrophages from mice deficient in complement component 5
Anellis et al. Production of Clostridium botulinum spores types A and B
SU492094A3 (ru) Способ получени живой брюшнотифозной вакцины
US4136169A (en) Cross-protective fowl cholera bacterins
KR19990076445A (ko) 동물성배지를 이용한 동충하초 재배방법
Byatt et al. Variation in pigment production in Staphylococcus aureus
Nungester et al. Variation of a Bacillus coli-like organism
Garrard A storage rot of potatoes caused by a fluorescent organism resembling Pseudomonas fluorescens (Flügge) Migula
RU2090612C1 (ru) Стимулятор роста бактериальной культуры
Thompson The value of vegetable extracts in culture mediums
Graham et al. Pleomorphic micro-organism associated with acute infectious avian laryngotracheitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20110905

Granted publication date: 20000927